Epsilon Medical

  • TOP
  • COMPANY
  • NEWS
  • Outcomes
  • Security Policy
  • LANGUAGE
    • EN
    • JP

News

TOP > News > 2022 > March
01

A specific clinical study at the University of Tsukuba has been published on jRCT

Following deliberation by the Clinical Research Review Committee of the University of Tsukuba, information on specific clinical research on our devices has been published on jRCT (Japan Registry of Clinical Trials, a clinical research submission and publication system).
  • Published: 2022年3月1日
  • Updated: 2024年12月18日
  • Author: admin_epmed
  • Category: NEWS

最近の投稿Recent Posts

  • The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our Endovascular EEG device (EP-01).
  • Regarding our company name change
  • Certified as a venture company originating from the University of Tsukuba
  • Series B funding from MedVenture Partners and DBJ Capital
  • A specific clinical study at the University of Tsukuba has been published on jRCT

アーカイブArchive

  • May 2025
  • December 2023
  • September 2023
  • March 2022
  • November 2021
  • October 2021

カテゴリーCategories

  • NEWS
@Epsilon Medical Inc.